Oneview Healthcare (ONE) H1 2024 earnings summary

Executive summary

• Reported first half 2024 results with operations spanning over 100 hospitals across 24 health systems on four continents, and a 16% year-to-date increase in contracted beds to 18,313, driven by four major new enterprise healthcare customers.

• Strong focus on scalability, cloud-based SaaS products, and a land-and-expand strategy, with all legacy customers migrated to the cloud and 100% of new sales cloud-based.

• Strategic partnership with Baxter International is delivering significant US market access, with over 100 opportunities in Baxter's pipeline and an expected 3,000–5,000 additional beds per year.

• Launched MyStay Mobile, expanding the addressable market by enabling patient access via personal devices, and completed successful pilots at NYU Langone Health.

• Leadership transition as CFO Helena D'Arcy steps down, succeeded by Dara Lyons, with new appointments in sales and customer success.

Financial highlights

• Recurring revenue up 8% year-over-year to €3.57 million; total revenue up 7% to €4.67 million (AUD 4.7 million reported in some sources).

• Gross margin increased by 8 percentage points to 73% (72.9% in some sources), with gross profit up to €3.40 million.

• Operating expenses rose 25% due to increased headcount for Baxter-related scaling.

• Operating EBITDA loss widened by €0.9 million to €3.71 million; net loss after tax increased 23% to €5.49 million.

• Cash balance at 30 June 2024 was €6.0 million, with no debt.

Outlook and guidance

• Material revenue growth expected in H2 2024 as delayed projects resume and new contracts go live.

• Focus on converting contracted beds to live beds and accelerating deployments, with scalability initiatives underway.

• Baxter partnership and MyStay Mobile launch anticipated to further expand US market penetration and drive revenue in 2025.

• No interim dividend is recommended.